Roche Holding
ISIN CH0012032113
|WKN 851311
Market cap (in EUR)
234,056.24 m
Country
Switzerland
Sector
Healthcare
Dividend yield
3.37%
Overview
Description
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
Healthcare Biopharmaceuticals Other Biopharmaceuticals Switzerland
Financials
Key metrics
| Market capitalisation, EUR | 234,056.24 m |
| EPS, EUR | - |
| P/B ratio | 7.21 |
| P/E ratio | 27.71 |
| Dividend yield | 3.37% |
Income statement (2024)
| Revenue, EUR | 63,551.97 m |
| Net income, EUR | 8,695.26 m |
| Profit margin | 13.68% |
What ETF is Roche Holding in?
There are 215 ETFs which contain Roche Holding. All of these ETFs are listed in the table below. The ETF with the largest weighting of Roche Holding is the UBS ETF (CH) SMIM (CHF) A-dis.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
